These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 12075203

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy.
    Juran NB.
    Am Heart J; 1999 Oct; 138(4 Pt 2):297-306. PubMed ID: 10502235
    [Abstract] [Full Text] [Related]

  • 6. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.
    N Engl J Med; 1998 May 21; 338(21):1488-97. PubMed ID: 9599103
    [Abstract] [Full Text] [Related]

  • 8. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
    Rukshin V, Shah PK, Cercek B, Finkelstein A, Tsang V, Kaul S.
    Circulation; 2002 Apr 23; 105(16):1970-5. PubMed ID: 11997285
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
    Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM, 'A to Z' Investigators.
    JAMA; 2004 Jul 07; 292(1):55-64. PubMed ID: 15238591
    [Abstract] [Full Text] [Related]

  • 10. What have We learned from ESPRIT? What will we learn from TARGET?
    Ferguson JJ.
    J Invasive Cardiol; 2000 Jun 07; 12(6):317-9. PubMed ID: 10859719
    [No Abstract] [Full Text] [Related]

  • 11. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial).
    Bonz AW, Lengenfelder B, Strotmann J, Held S, Turschner O, Harre K, Wacker C, Waller C, Kochsiek N, Meesmann M, Neyses L, Schanzenbächer P, Ertl G, Voelker W.
    J Am Coll Cardiol; 2002 Aug 21; 40(4):662-8. PubMed ID: 12204495
    [Abstract] [Full Text] [Related]

  • 12. Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes.
    Harrington RA.
    Am Heart J; 1999 Oct 21; 138(4 Pt 2):276-86. PubMed ID: 10502233
    [Abstract] [Full Text] [Related]

  • 13. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators.
    N Engl J Med; 1998 May 21; 338(21):1498-505. PubMed ID: 9599104
    [Abstract] [Full Text] [Related]

  • 14. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG.
    Chest; 2008 Jun 21; 133(6 Suppl):670S-707S. PubMed ID: 18574276
    [Abstract] [Full Text] [Related]

  • 15. [Advances in adjunctive pharmacological therapy for percutaneous coronary interventions].
    Benito B, Masotti M, Betriu A.
    Rev Esp Cardiol; 2005 Jun 21; 58(6):729-43. PubMed ID: 15970124
    [Abstract] [Full Text] [Related]

  • 16. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A, Halperin JL.
    Thromb Haemost; 2008 Nov 21; 100(5):752-3. PubMed ID: 18989515
    [No Abstract] [Full Text] [Related]

  • 17. Antiplatelet agents and arterial thrombosis.
    Billett HH.
    Cardiol Clin; 2008 May 21; 26(2):189-201, vi. PubMed ID: 18406994
    [Abstract] [Full Text] [Related]

  • 18. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR, ACC/AHA.
    J Invasive Cardiol; 2002 Dec 21; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [Abstract] [Full Text] [Related]

  • 19. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V, Marín F.
    Thromb Haemost; 2008 Nov 21; 100(5):754-5. PubMed ID: 18989516
    [No Abstract] [Full Text] [Related]

  • 20. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW, On-TIME 2 Trial Investigators.
    J Invasive Cardiol; 2012 Mar 21; 24(3):84-9. PubMed ID: 22388296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.